A detailed history of Round Rock Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Round Rock Advisors, LLC holds 20,833 shares of PFE stock, worth $594,990. This represents 0.14% of its overall portfolio holdings.

Number of Shares
20,833
Previous 25,011 16.7%
Holding current value
$594,990
Previous $694,000 16.14%
% of portfolio
0.14%
Previous 0.17%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$25.26 - $29.6 $105,536 - $123,668
-4,178 Reduced 16.7%
20,833 $582,000
Q1 2024

Apr 24, 2024

BUY
$25.89 - $29.73 $3,831 - $4,400
148 Added 0.6%
25,011 $694,000
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $297,829 - $386,848
-11,398 Reduced 31.43%
24,863 $715,000
Q2 2023

Jul 20, 2023

BUY
$36.12 - $41.79 $34,097 - $39,449
944 Added 2.67%
36,261 $1.33 Million
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $164,847 - $214,606
-4,185 Reduced 10.59%
35,317 $1.44 Million
Q4 2022

Jan 19, 2023

SELL
$41.75 - $54.5 $4,467 - $5,831
-107 Reduced 0.27%
39,502 $0
Q3 2022

Oct 20, 2022

BUY
$43.76 - $53.42 $323,824 - $395,308
7,400 Added 22.97%
39,609 $1.73 Million
Q2 2022

Jul 22, 2022

BUY
$46.53 - $55.17 $258,334 - $306,303
5,552 Added 20.83%
32,209 $1.69 Million
Q1 2022

Apr 28, 2022

BUY
$45.75 - $56.69 $754,783 - $935,271
16,498 Added 162.4%
26,657 $1.38 Million
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $126,563 - $187,608
3,063 Added 43.17%
10,159 $600,000
Q3 2021

Oct 25, 2021

BUY
$39.25 - $50.42 $24,570 - $31,562
626 Added 9.68%
7,096 $305,000
Q2 2021

Aug 05, 2021

BUY
$35.91 - $40.68 $31,636 - $35,839
881 Added 15.76%
6,470 $253,000
Q4 2020

Feb 19, 2021

BUY
$33.47 - $42.56 $187,063 - $237,867
5,589 New
5,589 $205,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Round Rock Advisors, LLC Portfolio

Follow Round Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Round Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Round Rock Advisors, LLC with notifications on news.